Zinc / amino acid-functionalized silica

US11186489B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11186489-B2
Application numberUS-201816206671-A
CountryUS
Kind codeB2
Filing dateNov 30, 2018
Priority dateDec 5, 2017
Publication dateNov 30, 2021
Grant dateNov 30, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein is zinc/amino acid functionalized silica, compositions comprising the same, and oral care methods and uses for such compositions.

First claim

Opening claim text (preview).

What is claimed: 1. A functionalized silica particle comprising a prophy silica having an average particle size of 5 to 20 microns; and a zinc-amino acid complex adsorbed to a surface of said silica, wherein the zinc-amino acid complex comprises zinc-lysine complex and/or zinc-arginine complex having a structure selected from one or more of [Zn(AA) 3 X] + , [Zn(AA) 2 X] + , [Zn(AA)X] + , [Zn(AA) 3 ] 2+ , [Zn(AA) 2 ] 2+ , [Zn(AA)] 2+ , wherein AA is lysine or arginine and wherein X is a halide, or another monovalent anion. 2. The functionalized silica particle according to claim 1 , wherein the zinc-amino acid complex comprises zinc-lysine complex having a structure selected from one or more of [Zn(AA) 3 X] + , [Zn(AA) 2 X] + , [Zn(AA)X] + , [Zn(AA) 3 ] 2+ , [Zn(AA) 2 ] 2+ , [Zn(AA)] 2+ , wherein AA is lysine, and wherein X is a halide or another monovalent anion. 3. The functionalized silica particle according to claim 1 , wherein the zinc-amino acid complex comprises zinc-arginine complex having a structure selected from one or more of [Zn(AA) 3 X] + , [Zn(AA) 2 X] + , [Zn(AA)X] + , [Zn(AA) 3 ] 2+ , [Zn(AA) 2 ] 2+ , [Zn(AA)] 2+ , wherein AA is arginine, and wherein X is a halide, or another monovalent anion. 4. The functionalized silica particle according to claim 2 wherein X is chloride. 5. The functionalized silica particle according to claim 1 , wherein the silica has an N 2 BET surface area of 200-1200 m 2 /g. 6. The functionalized silica particle according to claim 1 , wherein the silica has an N 2 BET surface area of 600 to 800 m 2 /g and an average particle size of 14 to 18 microns. 7. The functionalized silica particle according to claim 1 , wherein the functionalized silica contains from 0.1 to 10 mg of zinc/amino acid per 100 mg of silica. 8. The functionalized silica particle according to claim 1 , comprising from about 0.1 wt % to about 30 wt % zinc/amino acid, optionally wherein the zinc to amino acid molar ratio is from 5:1 to 1:5. 9. An oral care composition comprising a functionalized silica particle according to claim 1 . 10. The oral care composition according to claim 9 , wherein the composition comprises from 0.1 to 50% by weight of functionalized silica particles. 11. The oral care composition according to claim 9 , further comprising a metal salt. 12. The oral care composition according to claim 11 , wherein the metal salt comprises zinc oxide, zinc citrate, zinc lactate, zinc phosphate, or a combination thereof. 13. The oral care composition according to claim 9 , further comprising a basic amino acid, in free or orally acceptable salt form. 14. The oral care composition according to claim 9 , in the form of a toothpaste, gel, mouthwash, powder, cream, strip, thin film, or gum. 15. The oral care composition according to claim 14 , in the form of a toothpaste, gel or mouthwash. 16. The oral care composition according to claim 9 , further comprising an effective amount of a fluoride ion source. 17. A method of treating a disease, disorder or condition of the oral cavity, comprising the step of administering to a patient in need thereof an oral care composition according to claim 9 , to deliver zinc to the oral cavity, optionally, wherein said patient suffers from a disease, disorder or condition of the oral cavity, such as gingivitis, periodontitis, halitosis, cavity formation, enamel erosion, and/or oral infection. 18. The functionalized silica particle according to claim 4 , wherein the functionalized silica is made by incubating silica particles in an aqueous solution of a zinc-amino acid-halide complex having the structure [Zn(lysine) 2 Cl] + Cl −.

Assignees

Inventors

Classifications

  • Porous; Hollow · CPC title

  • C01B33/18Primary

    Preparation of finely divided silica neither in sol nor in gel form; After-treatment thereof (preparation of aerogels by dehydrating gels C01B33/158; treatment to enhance the pigmenting or filling properties C09C) · CPC title

  • Zinc; Compounds thereof · CPC title

  • Silicon; Compounds thereof · CPC title

  • Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11186489B2 cover?
Disclosed herein is zinc/amino acid functionalized silica, compositions comprising the same, and oral care methods and uses for such compositions.
Who is the assignee on this patent?
Colgate Palmolive Co
What technology area does this patent fall under?
Primary CPC classification C01B33/18. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).